Randomized Trials for the Treatment of Burning Mouth Syndrome: An Evidence-Based Review of the Literature

Moraes, Maiara de; Lima, Emeline das Neves de Araújo; Matos, Felipe Rodrigues de; Pinto, Leão Pereira; Costa, Antônio de Lisboa Lopes

doi:10.1016/j.oooo.2013.12.366

Cited by 6 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life Many drug treatments including antidepressants, dietary supplements, hormone-replacement therapy, and psychological support have been proposed, but the management of iBMS remains unsatisfactory (13,14).…”

Section: Originalmentioning

confidence: 99%

The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life

Boucher

2016

J Oral Sci

View full text Add to dashboard Cite

In this descriptive study, we investigated the relationship between the clinical characteristics of idiopathic burning mouth syndrome (iBMS) and the quality of life. Eighteen iBMS patients were interviewed about their experience with pain, oral-associated complaints, cognitive status, and selfperceived quality of life using the French versions of the Hospital Anxiety and Depression Scale (HADS) and the Global Oral Health Assessment Index (GOHAI). The Spearman coefficient was used to analyze correlations. The level of significance was fixed at P < 0.05. The majority of patients described the association of oral burning sensations with other oral complaints, including dry mouth (77.8%), tactile abnormalities (66.7%), thermal abnormalities (44.5%), and taste disturbances (38.9%). HADanxiety scores were higher than 10 in 38.8% of iBMS patients and HAD-depression scores were higher than 10 in 33.3% of patients. A significant correlation was found between the number of associated complaints and HAD-depression scores. The mean GOHAI-add score was 37.9 ± 9.6 (mean ± SD), and 94.5% of iBMS patients had a score lower than 50. GOHAI-add scores strongly correlated with pain intensity, which was calculated using a visual analog scale and duration of pain. Our findings indicate a strong correlation between iBMS-related pain and self-perceived oral health-related quality of life. In addition, a correlation was observed between iBMS-associated oral complaints and cognitive status. (J Oral Sci 58, 475-481, 2016)

show abstract

Section: Originalmentioning

confidence: 99%

The relationship between the clinical features of idiopathic burning mouth syndrome and self-perceived quality of life

Boucher

2016

J Oral Sci

View full text Add to dashboard Cite

show abstract

“…Aujourd'hui un consensus est établi autour d'une origine neuropathique périphérique et/ou centrale. Les symptômes ressentis par les patients étant semblables à ceux ressentis lors des névromes traumatiques ou des névrites, certains auteurs ont proposé qu'une atteinte nerveuse périphé-rique pouvait être responsable des stomatodynies [2,3,5,9]. Une classification selon l'origine de la pathologie a été établie : neuropathie périphérique des fibres orales de petit calibre (50-60 % des cas), neuropathie infra-clinique des fibres majeures trigéminales (20-25 % des cas) et déficit Tableau I.…”

Section: Physiopathologie Et éTiologiesunclassified

“…Plusieurs revues de la littérature [3,15,16] compilant plusieurs essais cliniques randomisés évaluant les différents traitements du BMS ont montré qu'il n'y a pas de traitement systématiquement efficace. De plus, les différences de tailles des échantillons des différents essais et de suivi des patients compliquent la lecture des résultats et l'émergence d'un traitement plus efficace qu'un autre.…”

Section: Traitementsunclassified

“…La pathologie évolue depuis au moins 4 à 6 mois [1][2][3][4][5]. La douleur est continue, modérée à sévère, souvent variable au cours de la journée : faible le matin, elle augmente souvent au cours de la journée mais ne perturbe que rarement le sommeil des patients.…”

Section: Introductionunclassified

“…Il n'existe pas un traitement systématiquement efficace, ce qui conduit à une situation stressante pour le patient. Les BMS affecteraient 1 % à 18 % (voire 40 % d'après certains auteurs) de la population et essentiellement des femmes (1:2,5 à 1:7 en faveur des femmes) autour de la ménopause (90 % des cas) [2][3][4]6]. Cette grande disparité dans la prévalence montre qu'il existe une difficulté diagnostique, principalement à cause de critères cliniques parfois peu clairs ou mal interprétés.…”

Section: Introductionunclassified

See 2 more Smart Citations